Production of the first batch of a Polish anti-Covid-19 drug derived from convalescent blood plasma began yesterday at the laboratories of Biomed Lublin, one of the biggest pharmaceutical companies in the country. The drug will contain isolated...
Production of the first batch of a Polish anti-Covid-19 drug derived from convalescent blood plasma began yesterday at the laboratories of Biomed Lublin, one of the biggest pharmaceutical companies in the country. The drug will contain isolated...
